Other Species / Isoforms
  NUMBL (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
S48-p
TMNKLRQsLRRRKPA
0 5
NUMBL (human) TMNKLRQsLRRRKPA S48-p
NUMBL (mouse) TMNKLRQsLRRRKPA S48-p
NUMBL (rat) TMNKLRQSLRRRKPA S48
Y56
LRRRKPAYVPEASRP
0 1
NUMBL (human) LRRRKPAYVPEASRP Y56
NUMBL (mouse) LRRRKPAyVPEAsRP Y56-p
NUMBL (rat) LRRRKPAYVPEASRP Y56
S61
PAYVPEASRPHQWQA
0 1
NUMBL (human) PAYVPEASRPHQWQA S61
NUMBL (mouse) PAyVPEAsRPHQWQA S61-p
NUMBL (rat) PAYVPEASRPHQWQA S61
T209-p
REKECGVtAAFDASR
0 1
NUMBL (human) REKECGVtAAFDASR T209-p
NUMBL (mouse) REKECGVTAAFDASR T209
NUMBL (rat) REKECGVTAAFDASR T209
S224-p
TSFAREGsFRLsGGG
0 14
NUMBL (human) TSFAREGsFRLsGGG S224-p
NUMBL (mouse) TSFAREGsFRLsGGG S224-p
NUMBL (rat) TSFAREGSFRLSGGG S224
S228-p
REGsFRLsGGGRPAE
0 6
NUMBL (human) REGsFRLsGGGRPAE S228-p
NUMBL (mouse) REGsFRLsGGGRPAE S228-p
NUMBL (rat) REGSFRLSGGGRPAE S228
S263-p
PAQPGHVsPtPAtTs
0 18
NUMBL (human) PAQPGHVsPtPAtTs S263-p
NUMBL (mouse) PAQPGHVsPtPAtts S263-p
NUMBL (rat) PAQPGHVSPTPATTS S262
T265-p
QPGHVsPtPAtTsPG
0 4
NUMBL (human) QPGHVsPtPAtTsPG T265-p
NUMBL (mouse) QPGHVsPtPAttsPG T265-p
NUMBL (rat) QPGHVSPTPATTSPG T264
T268-p
HVsPtPAtTsPGEKG
0 3
NUMBL (human) HVsPtPAtTsPGEKG T268-p
NUMBL (mouse) HVsPtPAttsPGEKG T268-p
NUMBL (rat) HVSPTPATTSPGEKG T267
T269
VsPtPAtTsPGEKGE
0 2
NUMBL (human) VsPtPAtTsPGEKGE T269
NUMBL (mouse) VsPtPAttsPGEKGE T269-p
NUMBL (rat) VSPTPATTSPGEKGE T268
S270-p
sPtPAtTsPGEKGEA
0 3
NUMBL (human) sPtPAtTsPGEKGEA S270-p
NUMBL (mouse) sPtPAttsPGEKGEA S270-p
NUMBL (rat) SPTPATTSPGEKGEA S269
T279-p
GEKGEAGtPVAAGTT
Upstream
0 17
Treatment
  • vemurafenib
NUMBL (human) GEKGEAGtPVAAGTT T279-p
NUMBL (mouse) GEKGEAGtPVAAGtT T279-p
NUMBL (rat) GEKGEAGTPVAAGTT T278
T285
GtPVAAGTTAAAIPR
0 1
NUMBL (human) GtPVAAGTTAAAIPR T285
NUMBL (mouse) GtPVAAGtTAAAIPR T285-p
NUMBL (rat) GTPVAAGTTAAAIPR T284
S305-p
EQLVRQGsFRGFPAL
Upstream
1 23
Treatment
  • LRRK2-IN-1
NUMBL (human) EQLVRQGsFRGFPAL S305-p
NUMBL (mouse) EQLVRQGsFRGFPAL S305-p
NUMBL (rat) EQLVRQGsFRGFPAL S304-p
S313-p
FRGFPALsQKNsPFK
0 5
NUMBL (human) FRGFPALsQKNsPFK S313-p
NUMBL (mouse) FRGFPALsQKNsPFK S313-p
NUMBL (rat) FRGFPALSQKNSPFK S312
S317-p
PALsQKNsPFKRQLs
0 10
NUMBL (human) PALsQKNsPFKRQLs S317-p
NUMBL (mouse) PALsQKNsPFKRQLs S317-p
NUMBL (rat) PALSQKNSPFKRQLS S316
S324-p
sPFKRQLsLRLNELP
0 27
NUMBL (human) sPFKRQLsLRLNELP S324-p
NUMBL (mouse) sPFKRQLsLRLNELP S324-p
NUMBL (rat) SPFKRQLSLRLNELP S323
T409-p
FQPGHKRtPsEAERW
0 7
NUMBL (human) FQPGHKRtPsEAERW T409-p
NUMBL (mouse) FQPGHKRtPsEAERW T409-p
NUMBL (rat) FQPGHKRTPsEAERW T408
S411-p
PGHKRtPsEAERWLE
Upstream
0 21
Treatment
  • BI_4834
  • ischemia
NUMBL (human) PGHKRtPsEAERWLE S411-p
NUMBL (mouse) PGHKRtPsEAERWLE S411-p
NUMBL (rat) PGHKRTPsEAERWLE S410-p
S421-p
ERWLEEVsQVAKAQQ
0 1
NUMBL (human) ERWLEEVsQVAKAQQ S421-p
NUMBL (mouse) ERWLEEVSQVAKAQQ S421
NUMBL (rat) ERWLEEVSQVAKAQQ S420